FDA approves Quidel's osteoporosis device:
This article was originally published in Clinica
The US FDA has approved Quidel's portable ultrasound device for helping to diagnose osteoporosis. The QUS-2, a self-contained, battery operated device, assesses the density of bone in the heel and provides quantitative results. It uses a dry scanning technology that precisely locates an optimal measurement site within the heel, said San Diego, California-based Quidel. The company added that the device's ability to discriminate fracture status was similar to that of X-ray bone density techniques of the spine and hip.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.